Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 4
2016 2
2017 2
2018 1
2019 3
2020 6
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
[Acute respiratory distress syndrome].
Kersten A, Cornelissen C. Kersten A, et al. Among authors: cornelissen c. Pneumologe (Berl). 2020;17(4):238-248. doi: 10.1007/s10405-020-00326-5. Epub 2020 May 18. Pneumologe (Berl). 2020. PMID: 32837493 Free PMC article. Review. German.
Causal treatment, apart from treatment of underlying infections, is still not available. Survivors of ARDS very often face relevant long-term sequelae....
Causal treatment, apart from treatment of underlying infections, is still not available. Survivors of ARDS very often face relevant long- …
Serum phosphate and phosphate-regulatory hormones in COPD patients.
Stroda A, Brandenburg V, Daher A, Cornelissen C, Goettsch C, Keszei A, Dreher M. Stroda A, et al. Among authors: cornelissen c. Respir Res. 2018 Sep 20;19(1):183. doi: 10.1186/s12931-018-0889-6. Respir Res. 2018. PMID: 30236113 Free PMC article.
We measured concentrations of intact FGF23 (iFGF23) and c-terminal FGF23 (c-term FGF23), phosphate, parathyroid hormone (PTH) and C-reactive protein (CRP) levels in COPD patients and controls. RESULTS: Phosphate (1.0 02 vs. 1.1 0.2 mmol/L; p = 0.027), PTH (54.2 29.4 vs. 68 …
We measured concentrations of intact FGF23 (iFGF23) and c-terminal FGF23 (c-term FGF23), phosphate, parathyroid hormone (PTH) and C-r …
ENDOXY - Development of a Biomimetic Oxygenator-Test-Device.
Dietrich M, Finocchiaro N, Olszweski S, Arens J, Schmitz-Rode T, Sachweh J, Jockenhoevel S, Cornelissen CG. Dietrich M, et al. Among authors: cornelissen cg. PLoS One. 2015 Dec 18;10(12):e0142961. doi: 10.1371/journal.pone.0142961. eCollection 2015. PLoS One. 2015. PMID: 26682907 Free PMC article.
Due to limited biocompatibility, current oxygenators do not allow mid- to long-term therapy. Tissue engineering uses autologous cell sources to overcome the immunogenic barriers of biomaterials. ...
Due to limited biocompatibility, current oxygenators do not allow mid- to long-term therapy. Tissue engineering uses autologous cell …
EndOxy: Dynamic Long-Term Evaluation of Endothelialized Gas Exchange Membranes for a Biohybrid Lung.
Klein S, Hesselmann F, Djeljadini S, Berger T, Thiebes AL, Schmitz-Rode T, Jockenhoevel S, Cornelissen CG. Klein S, et al. Among authors: cornelissen cg. Ann Biomed Eng. 2020 Feb;48(2):747-756. doi: 10.1007/s10439-019-02401-2. Epub 2019 Nov 21. Ann Biomed Eng. 2020. PMID: 31754901 Free PMC article.
In the concept of a biohybrid lung, endothelial cells seeded on gas exchange membranes form a non-thrombogenic an anti-inflammatory surface to overcome the lacking hemocompatibility of today's oxygenators during extracorporeal membrane oxygenation. To evaluate this concept, the l …
In the concept of a biohybrid lung, endothelial cells seeded on gas exchange membranes form a non-thrombogenic an anti-inflammatory surface …
Toward a digital decision- and workflow-support system for initiation and control of long-term non-invasive ventilation in stable hypercapnic COPD patients.
Cornelissen CG, Winter S, Keuchel D, Spicher N, Boeckmann B, Stephan C, Saygi T, Windisch W, Vollmer T, Dreher M. Cornelissen CG, et al. Ther Adv Chronic Dis. 2022 May 25;13:20406223221099338. doi: 10.1177/20406223221099338. eCollection 2022. Ther Adv Chronic Dis. 2022. PMID: 35651648 Free PMC article.
The DIGIVENT project established and implemented such algorithms for patients with chronic hypercapnic respiratory failure due to chronic obstructive pulmonary disease (COPD) by a predefined process. METHODS: Based on long-term clinical experience and guideline recommendat …
The DIGIVENT project established and implemented such algorithms for patients with chronic hypercapnic respiratory failure due to chronic ob …
EndOxy: Mid-term stability and shear stress resistance of endothelial cells on PDMS gas exchange membranes.
Hellmann A, Klein S, Hesselmann F, Djeljadini S, Schmitz-Rode T, Jockenhoevel S, Cornelissen CG, Thiebes AL. Hellmann A, et al. Among authors: cornelissen cg. Artif Organs. 2020 Oct;44(10):E419-E433. doi: 10.1111/aor.13712. Epub 2020 May 14. Artif Organs. 2020. PMID: 32320079
In this study, we investigated the mid-term shear stress resistance as well as gas transfer rates and cell densities of endothelial cells seeded on RGD-conjugated polydimethylsiloxane (RGD-PDMS) gas exchange membranes under dynamic conditions. ...Gas transfer (GT) tests re …
In this study, we investigated the mid-term shear stress resistance as well as gas transfer rates and cell densities of endothelial c …
Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab.
Ziemssen T, Lang M, Tackenberg B, Schmidt S, Albrecht H, Klotz L, Haas J, Lassek C, Cornelissen C, Ettle B; PANGAEA Study Group. Ziemssen T, et al. Among authors: cornelissen c. Mult Scler Relat Disord. 2020 Apr;39:101893. doi: 10.1016/j.msard.2019.101893. Epub 2019 Dec 13. Mult Scler Relat Disord. 2020. PMID: 31865273 Free article.
BACKGROUND: The risk of progressive multifocal leukoencephalopathy limits the duration over which patients can receive natalizumab before requiring a switch to other therapies such as fingolimod. To date, no studies have assessed the long-term real-world effectiveness and …
BACKGROUND: The risk of progressive multifocal leukoencephalopathy limits the duration over which patients can receive natalizumab before re …
The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study.
Ness NH, Haase R, Kern R, Schriefer D, Ettle B, Cornelissen C, Akguen K, Ziemssen T. Ness NH, et al. Among authors: cornelissen c. J Med Internet Res. 2020 Mar 17;22(3):e17921. doi: 10.2196/17921. J Med Internet Res. 2020. PMID: 32181745 Free PMC article.
However, there is no validated health resource survey available, preventing comparison of study results and meaningful conclusions regarding the efficiency of long-term treatments. OBJECTIVE: The aim of this study was to develop and validate a tablet- and paper-based MS he …
However, there is no validated health resource survey available, preventing comparison of study results and meaningful conclusions regarding …
Spraying Respiratory Epithelial Cells to Coat Tissue-Engineered Constructs.
Thiebes AL, Albers S, Klopsch C, Jockenhoevel S, Cornelissen CG. Thiebes AL, et al. Among authors: cornelissen cg. Biores Open Access. 2015 Jun 1;4(1):278-87. doi: 10.1089/biores.2015.0015. eCollection 2015. Biores Open Access. 2015. PMID: 26309803 Free PMC article.
Lactate dehydrogenase-levels in the culture medium increased the first day after spraying but normalized afterward. In the short term, no differences by means of morphology and expression-specific markers for vSMCs and RECs were seen between the control and study group. In …
Lactate dehydrogenase-levels in the culture medium increased the first day after spraying but normalized afterward. In the short term …
Real-world persistence and benefit-risk profile of fingolimod over 36 months in Germany.
Ziemssen T, Lang M, Tackenberg B, Schmidt S, Albrecht H, Klotz L, Haas J, Lassek C, Couto CA, Findlay JA, Cornelissen C; PANGAEA study group. Ziemssen T, et al. Among authors: cornelissen c. Neurol Neuroimmunol Neuroinflamm. 2019 Mar 7;6(3):e548. doi: 10.1212/NXI.0000000000000548. eCollection 2019 May. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 30882022 Free PMC article.
OBJECTIVE: To assess the long-term real-world benefit-risk profile of fingolimod in patients with relapsing MS in Germany. ...
OBJECTIVE: To assess the long-term real-world benefit-risk profile of fingolimod in patients with relapsing MS in Germany. ...
21 results